Purdue Pharmaceuticals and the company’s owners have been sued by Idaho’s Attorney General for allegedly contributing to the opioid epidemic; the governor of Texas has signed a bill into law that will raise the state’s minimum age to purchase tobacco and tobacco-related products to 21; California law makers have agreed to a budget deal that will provide healthcare to young, low-income, undocumented immigrants.
Idaho Attorney General Lawrence Wasden has filed a lawsuit accusing Purdue Pharmaceuticals and the company’s owners, the Sackler family, of profiting off the opioid crisis, according to The Hill. The lawsuit alleges the company misled physicians into prescribing opioids over competing treatments despite the dangers and risks of addiction associated with opioids. Purdue has denied the claims and plans to fight them in court.
Texas Governor Greg Abbott has signed a bill into law that will increase the state’s minimum age to purchase tobacco products to 21, CNN reported. The law covers cigarettes, e-cigarettes, and other tobacco-related products. Supporters of the legislation, which will become effective September 1, 2019, believe that increasing the age requirement will reduce the risk of addiction.
California law makers have agreed to a budget deal that will provide health insurance benefits, through the state’s Medicaid program, to low-income, undocumented immigrants between the ages of 19 to 25, The Hill reported. The program would cost approximately $98 million per year and cover about 90,000 individuals. The budget agreement must first be approved by the full state Legislature before it is officially enacted.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
Report Reveals Mounting Burdens of Drug Shortages on US Health System
June 27th 2025Vizient's 2024 survey reveals a sharp rise in drug shortages across US health care, with pediatric care hit especially hard and labor costs soaring—but the true impact may go far beyond limited medication access, threatening to disrupt the very foundations of how health systems operate.
Read More